WAVE Life Sciences Ltd Stock
Price
Target price
€6.15
€6.15
1.650%
0.1
1.650%
€18.37
09.04.26 / Stuttgart Stock Exchange
WKN: A1436W / Symbol: WVE / Name: WAVE Life / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
WAVE Life Sciences Ltd Stock
WAVE Life Sciences Ltd gained 1.650% today.
The stock is one of the favorites of our community with 25 Buy predictions and 1 Sell predictions.
Based on the current price of 6.15 € the target price of 18 € shows a potential of 192.68% for WAVE Life Sciences Ltd which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for WAVE Life Sciences Ltd stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of WAVE Life Sciences Ltd in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of WAVE Life Sciences Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| WAVE Life Sciences Ltd | 1.650% | -4.000% | -46.903% | 29.310% | -59.732% | 49.254% | 15.652% |
| Intellia Therapeutics Inc | -3.210% | 3.866% | -0.463% | 82.972% | 51.422% | -64.127% | -80.061% |
| Chromadex Corp | -2.560% | 1.587% | -11.927% | -19.665% | -30.182% | 188.722% | -51.392% |
| Cardio3 Biosciences S.A. | -24.450% | 32.847% | -5.943% | -17.833% | 169.630% | -51.337% | -93.788% |
Comments
WAVE Life Sciences (WVE) had its price target lowered by Bank of America Corporation from $38.00 to $21.00. They now have a "buy" rating on the stock.
Show more
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (WVE) had its price target lowered by Wells Fargo & Company from $27.00 to $13.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (WVE) had its price target raised by Mizuho from $22.00 to $27.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for WVE provided by MarketBeat
